Urology Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Urology Devices Market Report is Segmented by Product (Instruments [Dialysis Devices and More], Consumables & Accessories [Biopsy Devices and More]), Technology (Minimally-Invasive Surgery Devices, Robotic Urologic Surgery Systems and More), Diseases (Kidney Diseases, Urinary Stones, and More), End User (Hospitals & Clinics, Dialysis Centres and More) and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Urology Devices Market Size and Share

Urology Devices Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Urology Devices Market Analysis by Mordor Intelligence

The urology devices market is valued at USD 39.65 billion in 2025 and is forecast to reach USD 55.55 billion by 2030, expanding at a 6.98% CAGR. Rising life expectancy is enlarging the patient base for urological disorders, while minimally invasive and robotic technologies shorten recovery times and lift procedure volumes. Home-based dialysis and self-catheterization are migrating treatments away from hospitals, and single-use devices are lowering infection risks that once constrained outpatient growth. Robotics, thulium fiber lasers, and AI-guided imaging systems justify premium pricing, and regulatory agencies in the United States and Europe are accelerating approvals for breakthrough platforms such as burst wave lithotripsy and AI-assisted robotic systems. Against this backdrop, the urology devices market continues to draw investment even as venture funding in broader med-tech contracts.

Key Report Takeaways

  • By product category, instruments captured 67.58% revenue share in 2024; consumables and accessories are advancing at an 8.54% CAGR through 2030.
  • By technology, minimally invasive surgery devices held 46.13% of the urology devices market share in 2024, while robotic urologic surgery systems are projected to expand at a 10.66% CAGR to 2030.
  • By disease, kidney-stone management accounted for 36.41% of the urology devices market size in 2024, whereas urinary incontinence solutions are forecast to grow at an 8.65% CAGR.
  • By end user, hospitals and clinics commanded 68.55% share of the urology devices market size in 2024, yet ambulatory surgical centers exhibit the fastest growth at an 8.78% CAGR through 2030.
  • By geography, North America led with 39.11% urology devices market share in 2024; Asia-Pacific is the fastest-growing region at a 9.12% CAGR to 2030. 

Segment Analysis

By Product: Instruments Lead While Consumables Accelerate

Instruments account for 67.58% of the urology devices market in 2024 because robotic systems, dialysis machines, and thulium lasers require sizable upfront purchases. Consumables and accessories are growing at an 8.54% CAGR as single-use ureteroscopes and catheters create predictable reorder cycles. Endoscopic visualization towers, lithotripters, and urodynamic carts anchor capital budgets, but revenue predictability now tilts toward disposables that match every case. The instruments subcategory remains pivotal when facilities pursue high-complexity surgeries that demand integrated imaging and navigation. Dialysis consoles like Fresenius 5008X, cleared to deliver high-volume hemodiafiltration, illustrate how incremental upgrades sustain replacement demand. On the consumables side, biodegradable ureteral stents and antimicrobial coatings are differentiating brands without adding reprocessing burdens.

In this context, the urology devices market size for consumables is on track to carve a larger revenue slice, especially in regions where cost-per-procedure transparency drives buyer preference. Instruments will keep dominating absolute value, but their growth rate will trail that of accessories because budget committees lengthen approval cycles for large capital outlays. Facilities that own older holmium YAG lasers increasingly redeploy them to lower-acuity cases while allocating fresh capital to thulium platforms, reinforcing a barbell spending pattern inside the urology devices market.

Market Segment Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Technology: Robotics Surge While AI Integration Accelerates

Minimally invasive surgery devices held 46.13% share of the urology devices market size in 2024, yet robotic systems are producing the steepest curve at a 10.66% CAGR. New entrants such as Medtronic’s Hugo are broadening customer choice beyond Intuitive Surgical and, by offering modular components, lowering adoption thresholds. AI modules layer computer vision onto optics, translating video feeds into actionable prompts that help shorten learning curves. Burst wave lithotripsy, delivered via compact ultrasound emitters, is further expanding the non-invasive toolkit and may cannibalize traditional shock-wave systems over the next decade.

Looking ahead, additive manufacturing is enabling patient-specific implants such as biodegradable ureteral stents with controlled elution profiles.[3]Yong-Hoon Kim, “Preliminary Investigation on Biodegradable Ureteral Stents Using 3D Printing,” MDPI, mdpi.com Integration between imaging AI and robotic arms is expected to automate sub-steps like calyx entry during percutaneous nephrolithotomy, refining efficiency benchmarks. The convergence of these modalities should deepen overall penetration and protect pricing power across the urology devices market.

By Disease: Kidney Stones Dominate While Incontinence Accelerates

Kidney-stone interventions represented 36.41% of disease-linked revenue in 2024, reflecting high recurrence rates that necessitate repeat lithotripsy or ureteroscopy. Innovations such as portable burst wave lithotripsy increase treatment accessibility by eliminating anesthesia, which may further widen case volumes. Urinary incontinence is the fastest-growing segment at an 8.65% CAGR, buoyed by favorable clinical data for miniaturized neuromodulation implants and growing patient willingness to seek care.

Benign prostatic hyperplasia remains a large installed base for surgical and device therapies, now augmented by an AMA CPT Category I code for Aquablation that becomes effective in 2026. Urological cancers are moving toward focal therapy under AI-assisted imaging guidance, while pelvic organ prolapse benefits from lighter mesh constructs that aim to balance tensile strength with biocompatibility. Together, these shifts diversify revenue channels inside the urology devices market.

Market Segment share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End-User: Hospitals Dominate While ASCs Gain Ground

Hospitals and clinics held 68.55% of global revenue in 2024 because they host complex reconstructive and oncologic cases that rely on comprehensive support services. Ambulatory surgical centers are expanding fastest at an 8.78% CAGR thanks to lower overhead structures that align with payer preferences for site-neutral reimbursement. Diagnostic cystoscopy volumes in ASCs have climbed steadily as infection-control protocols favor settings with streamlined workflows.

Home-care environments constitute an emerging frontier as portable dialysis and self-catheterization kits gain regulatory support. Dialysis chains are also piloting hub-and-spoke tele-monitoring to balance staffing constraints with patchy rural access. As clinical responsibilities diffuse, the urology devices market will spread revenue across a wider set of care settings.

Geography Analysis

North America preserved 39.11% global share in 2024 due to robust reimbursement, rapid regulatory pathways, and a well-entrenched installed base of robotic platforms. The FDA’s Breakthrough Device Program expedites access for technologies such as burst wave lithotripsy, allowing early revenue capture that feeds back into R&D budgets. The United States is also reallocating routine diagnostics into ambulatory venues, giving manufacturers new channels to place compact endoscopy towers. Canada and Mexico generate incremental growth through cross-border purchasing agreements that standardize device specifications and shorten procurement cycles.

Asia-Pacific is the fastest climber with a 9.12% CAGR through 2030. Aging populations in China, Japan, and South Korea expand procedure demand while public-sector reforms unlock capital budgets for advanced lasers and imaging. Olympus chose South Korea to launch next-generation BPH devices, a sign that multinational firms view the region as a proving ground for premium technologies. Venture financing pullbacks have lowered valuations, which may spur consolidation that helps well-capitalized incumbents accumulate regional footprints.

Europe is a mature but policy-driven market in which environmental legislation can reshape material choices overnight. The anticipated PFAS prohibition challenges suppliers of ePTFE-based catheters and vascular grafts, prompting accelerated research into fluorine-free coatings. Germany, France, and Italy remain demand anchors, yet hospitals here are steeply discounting high-volume consumables, pushing vendors to extract margin from value-added services. South America holds pockets of growth led by Brazil, where ANVISA’s e-labeling push may lower localization costs, easing compliance for exporters. The Middle East invests heavily in specialist hospitals while many African states prioritize low-cost dialysis and catheterization solutions, presenting tiered opportunities for the urology devices market.

Geography growth
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The urology devices market is moderately fragmented, with technology differentiation eclipsing scale as the main source of competitive edge. Boston Scientific’s USD 3.7 billion Axonics acquisition extends its sacral neuromodulation footprint and underscores how larger conglomerates buy their way into high-growth niches. Stryker’s USD 4.9 billion bid for Inari Medical illustrates similar logic in peripheral vascular cross-fertilization, broadening solution portfolios for overlapping surgeon customers.

Robotic surgery remains a focal battleground. Intuitive Surgical still commands a dominant installed base, yet Medtronic leverages hospital-wide purchasing relationships to seed its Hugo systems, often bundling them with energy devices and staplers. PROCEPT BioRobotics differentiates through water-jet tissue ablation and AI-directed planning, offering outcome data that resonates with value-based procurement teams. Consumables players contend on infection control and ergonomic design; Cook Medical’s single-use ureteroscope and Teleflex’s UroLift 2 exemplify fast-cycle updates that help retain accounts.

Strategic partnerships with software specialists supply computer-vision and machine-learning layers that hardware vendors cannot easily build in-house. Hospitals increasingly request interoperability, prompting vendors to publish open APIs. In parallel, sustainability pledges press companies to redesign packaging, which is gradually becoming a purchase criterion alongside price and performance inside the urology devices market.

Urology Devices Industry Leaders

  1. Baxter International Inc.

  2. Boston Scientific Corporation

  3. Becton, Dickinson and Company

  4. Olympus Corporation

  5. Fresenius Medical Care AG & Co. KGaA

  6. *Disclaimer: Major Players sorted in no particular order
Urology Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2025: Avvio Medical treated its first patients with a non-invasive kidney-stone therapy that could shift fragmentation procedures to outpatient clinics.
  • April 2025: Medtronic reported 98.5% success in its Expand URO trial, supporting broader rollout of the Hugo robotic-assisted surgery system
  • February 2025: .Neuspera’s ultra-mini neuromodulation implant met gold-standard endpoints for incontinence therapy, validating miniature leadless formats.
  • December 2024: Teleflex released the UroLift 2 System with Advanced Tissue Control, expanding BPH indications to prostates up to 100 g.

Table of Contents for Urology Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence Of Urologic Conditions
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements In Minimally-Invasive & Robotic Surgery
    • 4.2.4 Preference For Single-Use Endoscopes & Catheters
    • 4.2.5 AI-Enabled Imaging & Navigation Improving Procedural Throughput
    • 4.2.6 Home-Based Dialysis & Self-Catheterization Enabled By Tele-Urology
  • 4.3 Market Restraints
    • 4.3.1 Stringent Global Approval & Post-Market Surveillance Requirements
    • 4.3.2 High Capital & Procedure Costs Of Advanced Systems
    • 4.3.3 Sustainability Pressure On Single-Use Plastics & PFAS Coatings
    • 4.3.4 Shortage Of Trained Urology Surgeons & Nurses In Emerging Markets
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technology Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size and Growth Forecasts (Value-USD)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.1.1 Dialysis Devices
    • 5.1.1.2 Endoscopes & Endovision Systems
    • 5.1.1.3 Lasers & Lithotripsy Devices
    • 5.1.1.4 Robotic Surgical Systems
    • 5.1.1.5 Urodynamic Systems
    • 5.1.1.6 Imaging & Navigation Devices
    • 5.1.1.7 Bladder Management Devices
    • 5.1.1.8 Other Instruments
    • 5.1.2 Consumables & Accessories
    • 5.1.2.1 Dialysis Consumables
    • 5.1.2.2 Guidewires & Urinary Catheters
    • 5.1.2.3 Stents (Ureteral & Urethral)
    • 5.1.2.4 Biopsy Devices
    • 5.1.2.5 Disposable Ureteroscopes
    • 5.1.2.6 Continence Care Products
    • 5.1.2.7 Other Consumables & Accessories
  • 5.2 By Technology
    • 5.2.1 Minimally-Invasive Surgery Devices
    • 5.2.2 Robotic Urologic Surgery Systems
    • 5.2.3 AI-enabled Imaging & Navigation
    • 5.2.4 3-D Printed & Patient-specific Implants
    • 5.2.5 Other Emerging Technologies
  • 5.3 By Disease
    • 5.3.1 Kidney Diseases
    • 5.3.2 Urological Cancer & BPH
    • 5.3.3 Urinary Stones (Urolithiasis)
    • 5.3.4 Pelvic Organ Prolapse
    • 5.3.5 Urinary Incontinence
    • 5.3.6 Other Diseases
  • 5.4 By End-User
    • 5.4.1 Hospitals & Clinics
    • 5.4.2 Dialysis Centres
    • 5.4.3 Ambulatory Surgical Centres
    • 5.4.4 Home-care Settings
    • 5.4.5 Other End-Users
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 Baxter International Inc.
    • 6.3.2 Boston Scientific Corporation
    • 6.3.3 Becton, Dickinson and Company
    • 6.3.4 Cook Medical Incorporated
    • 6.3.5 Stryker Corporation
    • 6.3.6 Fresenius Medical Care AG & Co. KGaA
    • 6.3.7 Intuitive Surgical Inc.
    • 6.3.8 KARL STORZ SE & Co. KG
    • 6.3.9 Medtronic plc
    • 6.3.10 Olympus Corporation
    • 6.3.11 Coloplast A/S
    • 6.3.12 Teleflex Incorporated
    • 6.3.13 Cardinal Health Inc.
    • 6.3.14 Siemens Healthineers AG
    • 6.3.15 Dornier MedTech GmbH
    • 6.3.16 Richard Wolf GmbH
    • 6.3.17 Lumenis Ltd.
    • 6.3.18 ConvaTec Group plc
    • 6.3.19 Terumo Corporation
    • 6.3.20 HuiZhou MIMED Co. Ltd.

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Urology Devices Market Report Scope

As per the scope of the report, urological conditions include kidney stone disease (urolithiasis), incontinence in men and women, benign prostate hyperplasia (BPH), and noncancerous prostate swelling in men with increasing age, prostate cancer, and erectile dysfunction in men. Therefore, urologists utilize these devices for the treatment of urinary disorders. The Urology Devices Market is segmented by Product, Disease (Instruments, consumables, and Accessories), By Diseases(Kidney Diseases, Urological Cancer and BPH, Pelvic Organ Prolapse, Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (USD million) for the above segments.

By Product Instruments Dialysis Devices
Endoscopes & Endovision Systems
Lasers & Lithotripsy Devices
Robotic Surgical Systems
Urodynamic Systems
Imaging & Navigation Devices
Bladder Management Devices
Other Instruments
Consumables & Accessories Dialysis Consumables
Guidewires & Urinary Catheters
Stents (Ureteral & Urethral)
Biopsy Devices
Disposable Ureteroscopes
Continence Care Products
Other Consumables & Accessories
By Technology Minimally-Invasive Surgery Devices
Robotic Urologic Surgery Systems
AI-enabled Imaging & Navigation
3-D Printed & Patient-specific Implants
Other Emerging Technologies
By Disease Kidney Diseases
Urological Cancer & BPH
Urinary Stones (Urolithiasis)
Pelvic Organ Prolapse
Urinary Incontinence
Other Diseases
By End-User Hospitals & Clinics
Dialysis Centres
Ambulatory Surgical Centres
Home-care Settings
Other End-Users
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product
Instruments Dialysis Devices
Endoscopes & Endovision Systems
Lasers & Lithotripsy Devices
Robotic Surgical Systems
Urodynamic Systems
Imaging & Navigation Devices
Bladder Management Devices
Other Instruments
Consumables & Accessories Dialysis Consumables
Guidewires & Urinary Catheters
Stents (Ureteral & Urethral)
Biopsy Devices
Disposable Ureteroscopes
Continence Care Products
Other Consumables & Accessories
By Technology
Minimally-Invasive Surgery Devices
Robotic Urologic Surgery Systems
AI-enabled Imaging & Navigation
3-D Printed & Patient-specific Implants
Other Emerging Technologies
By Disease
Kidney Diseases
Urological Cancer & BPH
Urinary Stones (Urolithiasis)
Pelvic Organ Prolapse
Urinary Incontinence
Other Diseases
By End-User
Hospitals & Clinics
Dialysis Centres
Ambulatory Surgical Centres
Home-care Settings
Other End-Users
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

1. What is the current size of the urology devices market?

The urology devices market stands at USD 39.65 billion in 2025 and is projected to reach USD 55.55 billion by 2030.

2. Which product category holds the largest share?

Instruments such as robotic systems and dialysis machines captured 67.58% revenue share in 2024.

3. Which region is growing the fastest?

Asia-Pacific is expanding at a 9.12% CAGR through 2030 due to aging populations and rising healthcare investments.

4. Why are single-use devices gaining popularity?

They reduce infection risk and eliminate sterilization costs, making them attractive for ambulatory centers.

5. What technology is propelling growth in surgical procedures?

Robotic surgery platforms combined with AI-guided imaging are driving a 10.66% CAGR in the robotic segment.

6. How are environmental regulations affecting device materials?

An impending European ban on PFAS compounds is prompting manufacturers to seek fluorine-free alternatives for catheters and grafts.

Page last updated on: June 22, 2025

Urology Devices Market Report Snapshots

Compare market size and growth of Urology Devices Market with other markets in Healthcare Industry